Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FC60X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,479
Award facts
- Contract value 100% obligated
- $25,478.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,478.78 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pens. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions such as moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, indicating this delivery supports the Department of Defense's pharmaceutical supply chain for military and veteran healthcare needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. This arrangement reflects DLA's strategy to leverage prime vendor contracts for efficient distribution of specialized pharmaceutical products across the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FC60X?
SPE2DB25FC60X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FC60X worth?
The government has obligated $25,479 on SPE2DB25FC60X.
Is contract SPE2DB25FC60X an order under another contract?
Yes. SPE2DB25FC60X is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC60X competed?
The extent of competition for SPE2DB25FC60X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award